Table 7 Risk factor analysis of progression in 3 years after RNU
Variables | No progression n = 40 (%) | Progression n = 10 (%) | p-value | |
|---|---|---|---|---|
Age (years) | ≥ 70 | 24 (60.0) | 7 (70.0) | 0.7222 |
Gender | Male | 29 (72.5) | 8 (80.0) | 1.0000 |
Laterality | Right | 17 (42.5) | 6 (60.0) | 0.4804 |
Location of main tumor | Ureter | 19 (47.5) | 6 (60.0) | 0.7252 |
Hydronephrosis | Yes | 12 (30.0) | 3 (30.0) | 1.0000 |
Urine cytology | Positive | 19 (47.5) | 5 (50.0) | 1.0000 |
Urinary BTA | Positive | 18 (45.0) | 3 (30.0) | 0.4880 |
Urinary NMP22 | Positive | 18 (45.0) | 5 (50.0) | 1.0000 |
Diagnostic ureteroscopic biopsy | Yes | 12 (30.0) | 3 (30.0) | 1.0000 |
Multifocality | Multiple | 4 (10.0) | 0 (0.0) | 0.5710 |
Tumor size (cm) | ≥ 3 | 14 (35.0) | 8 (80.0) | 0.0836 |
Pathological T stage | ≥ 3 | 8 (20.0) | 8 (80.0) | 0.0007* |
Grade | 3 | 22 (55.0) | 9 (90.0) | 0.0145* |
LVI | Positive | 6 (15.0) | 6 (60.0) | 0.0073* |
INF | b, c | 28 (70.0) | 10 (100.0) | 0.0920 |
Pneumoretroperitoneum time (min) | ≥ 210 | 20 (50.0) | 5 (50.0) | 1.0000 |
Total operating time (min) | ≥ 360 | 19 (47.5) | 5 (50.0) | 1.0000 |
ASC | Yes | 12 (30.0) | 8 (80.0) | 0.0088* |